Losartan Potassium Tablet, Film Coated
Product Images NDC 0615-7959

9 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 0615-7959). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losapotatab1 (Losartan Potassium Tabs 7958 7959 7960 1)

Losapotatab1 (Losartan Potassium Tabs 7958 7959 7960 1)
Chemical structure diagram of Losartan Potassium showing its molecular components and arrangement, including potassium ion (K+).*
FDA Label Image

Losapotatab2 (Losartan Potassium Tabs 7958 7959 7960 2)

Losapotatab2 (Losartan Potassium Tabs 7958 7959 7960 2)
A line chart comparing the percentage of patients with primary endpoint occurrences over study months for Atenolol (dashed line) versus Losartan Potassium (solid line). The x-axis represents study months from 0 to 66, and the y-axis shows percentage of patients from 0 to 16%. The chart notes an adjusted risk reduction of 13% with Losartan Potassium (p=0.021).*
FDA Label Image

Losapotatab3 (Losartan Potassium Tabs 7958 7959 7960 3)

Losapotatab3 (Losartan Potassium Tabs 7958 7959 7960 3)
A line chart comparing the percentage of patients experiencing fatal or non-fatal stroke over study months between two drugs: Losartan Potassium and Atenolol. The graph shows a lower percentage of stroke events in patients treated with Losartan Potassium versus Atenolol, with an adjusted risk reduction of 25% and statistical significance (p=0.001). The x-axis represents study months up to 66, and the y-axis shows percentage of patients from 0 to 8%.*
FDA Label Image

Losapotatab (Losartan Potassium Tabs 7958 7959 7960 4)

Losapotatab (Losartan Potassium Tabs 7958 7959 7960 4)
This figure is a forest plot comparing the hazard ratios of Losartan Potassium versus Atenolol for primary composite and stroke (fatal/non-fatal) events across various patient subgroups, including age, gender, race, ischemic heart disease (ISH), diabetes, and cardiovascular disease (CVD) history. It presents event rates and 95% confidence intervals, indicating relative favorability between the two drugs.*
FDA Label Image

Losapotatab5 (Losartan Potassium Tabs 7958 7959 7960 5)

Losapotatab5 (Losartan Potassium Tabs 7958 7959 7960 5)
A line graph comparing the percentage of patients with events over time (in months) between Losartan Potassium Tablet and Placebo groups. The graph shows a risk reduction of 16.1% with a p-value of 0.022, indicating the difference between groups over 48 months.*
FDA Label Image

Principal Display Panel (Losartan Potassium Tabs 7958 7959 7960 6)

Principal Display Panel (Losartan Potassium Tabs 7958 7959 7960 6)
Losartan Potassium Tablets USP 25 mg label showing manufacturer Zydus and package by Vangard Labs, Glasgow, KY. Includes lot number, expiration date fields, quantity 30, storage instructions (20°-25°C), and multiple small barcode labels with the same product and lot information. Label advises dispensing in a tight, light-resistant container for institutional use only.*
FDA Label Image

Principal Display Panel (Losartan Potassium Tabs 7958 7959 7960 7)

Principal Display Panel (Losartan Potassium Tabs 7958 7959 7960 7)
Label for Losartan Potassium Tablets, USP 50 mg, film-coated oral tablets. The label includes barcode, lot number 7959, expiration date (not filled), and quantity of 30 tablets. Manufactured by Zydus and packaged by Vanguard Labs, Glasgow, KY 42141. Instructions include storage at 20-25°C, protection from light, and notation for institutional use only.*
FDA Label Image

Principal Display Panel (Losartan Potassium Tabs 7958 7959 7960 8)

Principal Display Panel (Losartan Potassium Tabs 7958 7959 7960 8)
Label sheet featuring multiple identical labels for Losartan Potassium Tablet, USP 50 mg, film-coated tablets. Each label includes the product name, dosage strength, barcode, lot number placeholder, and packaging information by Vangard Labs, Glasgow, KY. The lower portion shows a close-up of a full product label including quantity (30 tablets), storage instructions, and manufacturing information by Zydus for institutional use only.*
FDA Label Image

Principal Display Panel (Losartan Potassium Tabs 7958 7959 7960 9)

Principal Display Panel (Losartan Potassium Tabs 7958 7959 7960 9)
Packaging label for Losartan Potassium Tablets, USP 100 mg, film coated oral tablets. The label shows multiple barcodes, lot number 7960, and packaging by Vangard Labs in Glasgow, KY. It includes storage instructions, dosage unit per tablet, and a section for recording received dates and times. The label is marked for institutional use only and manufactured by Zydus.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.